📋 Tender Overview
Contract awarded for 2026/0448 - centralized aggregation for additional medications for the year 2026 lot-0006, title: denosumab [60 mg; sol inj; frs/seringa], description: denosumab [60 mg; sol inj; frs/seringa] lot-0012, title: nilotinib [150 mg; cáp/comp], description: nilotinib [150 mg; cáp/comp] estimated value excluding vat: 1958.88 eur.2026/0448 - centralized aggregation for additional medications for the year 2026
